A Coordinated Parent/Child Dyad Weight Loss Intervention: Dyad Plus (Feasibility)

March 17, 2023 updated by: Wake Forest University Health Sciences
The purpose of this research is to develop a coordinated program (Dyad Plus) that would help to facilitate self-monitoring, positive communication, joint problem solving, and social support to increase physical activity, healthy eating, and weight loss. Participants of the Brenner FIT (Families In Training) pediatric weight management program and their parent/guardian will co-enroll in weight loss programs. Parents/guardians will receive the components of By Design Essentials.

Study Overview

Detailed Description

Participation in this study will involve participation in six, one-hour sessions in addition to those required by your weight loss program. These sessions will work to facilitate an increase in self-monitoring, positive communication, problem solving, and social support to increase healthy physical activity and eating behaviors to increase the effectiveness of the weight loss programs. Joint goal setting and tracking will be enabled by commercially available devices and apps. Each caregiver and child will receive an activity monitor, activity app, and a food app (digital food diary) that allows self-monitoring of consumption and "social accountability," which will allow caregivers and the Brenner FIT team to monitor and encourage. Furthermore, two home visits will be conducted to evaluation the home food and activity environments to inform tailored feedback to families.

Brenner FIT is a family-based pediatric weight management clinic for youth 2-18 years old referred by a physician for overweight or obesity.11-14 By Design is an adult (>18yrs) weight loss clinic that includes tailored dietary and physical activity behavioral counseling. The preliminary data suggest that most adolescent youth who enroll in Brenner FIT have at least one adult caregiver who is eligible and would benefit from enrollment in By Design Essentials.

Study Type

Interventional

Enrollment (Actual)

16

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Carolina
      • Winston-Salem, North Carolina, United States, 27157
        • Wake Forest Baptist Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

13 years to 65 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Eligible for enrollment in Brenner FIT and/or By Design Essentials
  • Caregiver who lives in the house with a BMI > 30
  • No contraindication for physical activity or caloric restriction
  • Must be able to read and write English

Exclusion Criteria:

  • Over the age of 65
  • BMI < 30
  • Contraindication for physical activity or caloric restriction
  • Cannot read or write English

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Adolescents Participants
Adolescents will participate in the Dyad Plus program along with their caregivers. The Dyad plus program consist of the combination of two existing programs (Brenner FIT for adolescents and By Design for the adult caregivers) with a new, novel coordination component
Brenner FIT pediatric weight management program enrollment. an interdisciplinary, family-based pediatric weight management clinic based upon the Familial Approach to Treatment of Childhood Obesity. Patients are referred by a physician for obesity or overweight with a weight-related comorbidity. Treatment teams are comprised of a pediatrician, counselor, dietitian, and physical activity specialist, with others (e.g., social workers, physical therapists) as needed. The entire family is encouraged to attend all aspects of the treatment program, although only one attending caregiver is required.

This component adds four additional strategies: dyad group sessions, one-on-one parent/child communication sessions, joint goal setting/tracking, and home environment assessment. This innovative approach will seek to employ components of motivation and communication theories to increase self-monitoring, positive communication, problem solving, and social support to increase healthy physical activity and eating behaviors to increase the effectiveness of the weight loss programs beyond gains observed in matched controls.

Essentials (adults), with four additional components: dyad group sessions, one-on-one parent/child communication sessions, joint goal setting/tracking, and home environment assessment

Experimental: Caregivers of adolescents participants
Adult caregivers will participate in the Dyad Plus program along with their youth participants. The Dyad plus program consist of the combination of two existing programs (Brenner FIT for adolescents and By Design for the adult caregivers) with a new, novel coordination component

This component adds four additional strategies: dyad group sessions, one-on-one parent/child communication sessions, joint goal setting/tracking, and home environment assessment. This innovative approach will seek to employ components of motivation and communication theories to increase self-monitoring, positive communication, problem solving, and social support to increase healthy physical activity and eating behaviors to increase the effectiveness of the weight loss programs beyond gains observed in matched controls.

Essentials (adults), with four additional components: dyad group sessions, one-on-one parent/child communication sessions, joint goal setting/tracking, and home environment assessment

Weight loss program for adults/caregivers of those enrolled in Brenner FIT. Participants in the By Design condition (adult caregivers) will be prescribed the Essentials lifestyle intervention which includes tailored dietary and physical activity goals designed to achieve 1-2 lbs./week of weight loss, provided by a multidisciplinary team of medical providers, dietitians, behaviorists, and exercise specialists. A daily calorie restriction of 500 kcal/day is prescribed based on estimates of total energy expenditure (TEE) obtained from a measured resting metabolic rate (RMR) prior to enrollment.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
BMI z-score
Time Frame: Baseline
Weight status of caregivers and youth will be quantified through calculation of BMI derived from measurement of height and weight at the intake and follow-up visits. Both height (plus or minus 0.1 cm) and weight (plus or minus 0.5 kg) will be recorded twice and values will be averaged to produce the final value using a Tanita (registered trademark) digital scale and a Seca (registered trademark) Height Rod (respectively). BMI will be calculated as kg /m2. BMI z-score will be calculated using CDC growth charts.
Baseline
BMI z-score
Time Frame: 6 months
Weight status of caregivers and youth will be quantified through calculation of BMI derived from measurement of height and weight at the intake and follow-up visits. Both height (plus or minus 0.1 cm) and weight (plus or minus 0.5 kg) will be recorded twice and values will be averaged to produce the final value using a Tanita (registered trademark) digital scale and a Seca (registered trademark) Height Rod (respectively). BMI will be calculated as kg /m2. BMI z-score will be calculated using CDC growth charts.
6 months
BMI z-score
Time Frame: 3 Months
Weight status of caregivers and youth will be quantified through calculation of BMI derived from measurement of height and weight at the intake and follow-up visits. Both height (plus or minus 0.1 cm) and weight (plus or minus 0.5 kg) will be recorded twice and values will be averaged to produce the final value using a Tanita (registered trademark) digital scale and a Seca (registered trademark) Height Rod (respectively). BMI will be calculated as kg /m2. BMI z-score will be calculated using CDC growth charts.
3 Months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical Activity Assessed by Accelerometry
Time Frame: Baseline
Physical activity data will be collected using ActiGraph (trademark) accelerometers worn continuously over 7 days except during bathing and sleeping. Moderate to vigorous activity will be measured in minutes.
Baseline
Physical Activity Assessed by Accelerometry
Time Frame: 6 months
Physical activity data will be collected using ActiGraph (trademark) accelerometers worn continuously over 7 days except during bathing and sleeping. Moderate to vigorous activity will be measured in minutes.
6 months
Physical Activity Assessed by PAQ-A
Time Frame: Baseline

The Physical Activity Questionnaire for Adolescents (PAQ-A) will be given to assess physical activity.

The PAQ-A ranges from 1-7. Higher score denotes better outcome.

Baseline
Physical Activity Assessed by PAQ-A
Time Frame: 6 months

The Physical Activity Questionnaire for Adolescents (PAQ-A) will be given to assess physical activity.

The PAQ-A ranges from 1-7. Higher score denotes better outcome.

6 months
Physical Activity Assessed by IPAQ
Time Frame: Baseline

The International Physical Activity Questionnaire (IPAQ) will be given to assess physical activity in adults.

The IPAQ ranges from 10-960 minutes/day of physical activity. Higher score denotes better outcome.

Baseline
Physical Activity Assessed by IPAQ
Time Frame: 6 months

The International Physical Activity Questionnaire (IPAQ) will be given to assess physical activity in adults.

The IPAQ ranges from 10-960 minutes/day of physical activity. Higher score denotes better outcome.

6 months
Caloric intake expressed in kcals
Time Frame: Baseline
Diet will be assessed by the Automated Self-Administered 24-hour (ASA24) dietary assessment tool.
Baseline
Caloric intake expressed in kcals
Time Frame: 6 months
Diet will be assessed by the Automated Self-Administered 24-hour (ASA24) dietary assessment tool.
6 months
Concentration of fasting glucose for all participants, mg/dL
Time Frame: Baseline
Fasting blood glucose will be ascertained for each participant. A fasting blood sugar level less than 100 mg/dL (5.6 mmol/L) is optimal. A fasting blood sugar level from 100 to 125 mg/dL (5.6 to 6.9 mmol/L) is considered prediabetes.
Baseline
Concentration of fasting glucose for all participants, mg/dL
Time Frame: 6 months
Fasting blood glucose will be ascertained for each participant. A fasting blood sugar level less than 100 mg/dL (5.6 mmol/L) is optimal. A fasting blood sugar level from 100 to 125 mg/dL (5.6 to 6.9 mmol/L) is considered prediabetes.
6 months
Concentration of fasting Insulin for all participants, mg/dL
Time Frame: Baseline
Fasting insulin levels will be gathered from all participants.
Baseline
Concentration of fasting Insulin for all participants, mg/dL
Time Frame: 6 months
Fasting insulin levels will be gathered from all participants.
6 months
Hemoglobin A1c concentration for all participants, measured in percentage
Time Frame: 6 months
Normal range for the hemoglobin A1c level is between 4% and 5.6%. Hemoglobin A1c levels between 5.7% and 6.4%. Values greater denote diabetes.
6 months
Aspartate Aminotransferase -Levels of AST for all participants, measured in units per liter (IU/L)
Time Frame: Baseline
AST a useful test for detecting or monitoring liver damage.
Baseline
Aspartate Aminotransferase -Levels of AST for all participants, measured in units per liter (IU/L)
Time Frame: 6 months
AST a useful test for detecting or monitoring liver damage.
6 months
Alanine Aminotransferase-Levels of ALT for all participants, measured in units per liter
Time Frame: Baseline
A low level of ALT in the blood is expected and is normal.
Baseline
Alanine Aminotransferase-Levels of ALT for all participants, measured in units per liter
Time Frame: 6 months
A low level of ALT in the blood is expected and is normal.
6 months
Concentration of total cholesterol (mg/dL)
Time Frame: Baseline
total cholesterol: less than 200 mg/dL
Baseline
Concentration of total cholesterol (mg/dL)
Time Frame: 6 months
total cholesterol: less than 200 mg/dL
6 months
Hemoglobin A1c concentration for all participants, measured in percentage
Time Frame: Baseline
Normal range for the hemoglobin A1c level is between 4% and 5.6%. Hemoglobin A1c levels between 5.7% and 6.4% Values greater denote diabetes.
Baseline
Economic costs of the three intervention arms over duration of program (USD)
Time Frame: Baseline through 6 months
Clinical and non-clinical costs of the interventions will be compiled over the duration of the program. All cost will be reported in the same unit.
Baseline through 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 25, 2020

Primary Completion (Actual)

June 16, 2020

Study Completion (Actual)

June 16, 2020

Study Registration Dates

First Submitted

January 10, 2019

First Submitted That Met QC Criteria

January 18, 2019

First Posted (Actual)

January 22, 2019

Study Record Updates

Last Update Posted (Actual)

March 22, 2023

Last Update Submitted That Met QC Criteria

March 17, 2023

Last Verified

May 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pediatric Obesity

Clinical Trials on Brenner FIT

3
Subscribe